SCHEMBL8225522

SCHEMBL8225522

CCOC(=O)CN(CC(=O)OCC)Cc1cc(CCc2ccc(N)cc2)cc(CN(CC(=O)OCC)CC(=O)OCC)n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPIB P23284 1/20 0.42
PPIA P62937 1/20 0.42
PPID Q08752 1/20 0.42
PPIG Q13427 1/20 0.42
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
LMNA P02545 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAOA P21397 1/20 0.39
CYP19A1 P11511 3/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
HPGD P15428 1/20 0.37
SHMT2 P34897 1/20 0.37
PPARG P37231 1/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9356406 0.94 PPIB (0.40) PPIBPPIAPPIDPPIGCYP4F2
SCHEMBL10350456 0.88 PPIB (0.41) PPIBPPIAPPIDPPIGCYP4F2
SCHEMBL8229645 0.83 RAB9A (0.46) LMNAALDH1A1MAPTMEN1GAA
SCHEMBL10535744 0.81 GFER (0.41) MAOACYP19A1CA1CA2GFER
SCHEMBL8190164 0.81 CYP4A11 (0.43) CYP4F2CYP4A11ALDH1A1PPARGMEN1
SCHEMBL8186540 0.80 PPARA (0.39) CYP1A2ALDH1A1PPARGMEN1KMT2A
SCHEMBL9360196 0.78 RAB9A (0.46) LMNAALDH1A1MAPTMEN1GAA
SCHEMBL2367316 0.77 FFAR1 (0.35) PPIBPPIAPPIDPPIGLMNA
SCHEMBL10508451 0.76 L3MBTL1 (0.47) CYP4F2CYP4A11PPARGNPC1RAB9A
SCHEMBL9356014 0.75 GFER (0.38) MAOACYP19A1PPARGCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147250-A TREATING DISEASES MEDIATED BY VASCULAR CELL ADHESION MOLECULE-1, INCLUDING CARDIOVASCULAR AND INFLAMMATORY DISEASES; SUCCINOBUCOL ATHEROGENICS, INC. (US) 2000-11-14 US disclosed
US-6127529-A FORMS STABLE CHELATE COMPOUND USEFUL FOR LABELING BIOLOGICAL TARGETING COMPOUND RESIDUE WALLAC OY (FI) 2000-10-03 US disclosed
EP-0298939-B1 Metal-chelating 2,6-disubstituted pyridine compounds and their use WALLAC OY (FI) 1994-01-12 EP disclosed
EP-0298939-A1 Metal-chelating 2,6-disubstituted pyridine compounds and their use WALLAC OY (FI) 1989-01-11 EP disclosed